Essential Hypertension
Showing NaN - NaN of 6
Essential Hypertension Trial in Worldwide (Olmesartan medoxomil 40 mg - Amlodipine 10 mg, Olmesartan 40mg-Amlodipine
Completed
- Essential Hypertension
- Olmesartan medoxomil 40 mg - Amlodipine 10 mg
- +4 more
-
Graz, Austria
- +116 more
Dec 20, 2018
Essential Hypertension Trial in Worldwide (olmesartan medoxomil + amlodipine + hydroclororthiazide + , Olmesartan medoxomil +
Completed
- Essential Hypertension
- olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo
- +3 more
-
Antwerp, Belgium
- +132 more
Dec 20, 2018
Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets, olmesartan medoxomil
Completed
- Essential Hypertension
- olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets
- olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg
-
Brugge, Belgium
- +40 more
Dec 20, 2018
Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and , olmesartan
Completed
- Essential Hypertension
- olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo
- +2 more
-
Pleven, Bulgaria
- +54 more
Dec 20, 2018
Essential Hypertension Trial in United States (XOMA 985, Amlodipine Besylate, Perindopril Erbumine)
Completed
- Essential Hypertension
- XOMA 985
- +2 more
-
Huntsville, Alabama
- +47 more
Sep 8, 2015
